SCHEMBL6023441

SCHEMBL6023441

CCCCCOc1cc(/C=C/C(=O)N2CCN(c3ccc(NC(=N)c4cccs4)cc3)CC2)cc(OCCCCC)c1O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
THRB P10828 1/20 0.49
MAPT P10636 10/20 0.46
POLB P06746 2/20 0.46
HTT P42858 2/20 0.46
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 2/20 0.45
CYP2C19 P33261 1/20 0.45
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 1/20 0.42
MCL1 Q07820 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ACHE P22303 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6023444 1.00 KMT2A (0.49) KMT2AMEN1THRBMAPTPOLB
SCHEMBL6022674 0.99 KMT2A (0.51) KMT2AMEN1THRBMAPTPOLB
SCHEMBL6022601 0.99 KMT2A (0.51) KMT2AMEN1THRBMAPTPOLB
SCHEMBL7031592 0.99 KMT2A (0.51) KMT2AMEN1THRBMAPTPOLB
SCHEMBL6022599 0.99 KMT2A (0.51) KMT2AMEN1THRBMAPTPOLB
SCHEMBL6022676 0.99 KMT2A (0.51) KMT2AMEN1THRBMAPTPOLB
SCHEMBL7031596 0.99 KMT2A (0.51) KMT2AMEN1THRBMAPTPOLB
Hydrochloric Acid SCHEMBL6022870 0.98 KMT2A (0.50) KMT2AMEN1THRBMAPTPOLB
Hydrochloric Acid SCHEMBL6023228 0.98 KMT2A (0.50) KMT2AMEN1THRBMAPTPOLB
Hydrochloric Acid SCHEMBL6023229 0.98 KMT2A (0.50) KMT2AMEN1THRBMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US claimed
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 KMT2A 1377/4885MEN1 3297/4885THRB 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.